Fund Holdings — Euclidean Capital LLC

Total Portfolio Value:
$736.72M
Total Bought:
$26.20M
Total Sold:
$168.43M
Net Transaction:
-$142.23M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)1,202,804896,254-306,550$690.12M$525.28M71.30%-$164.84M
Ishares TrMSCI INDIA ETF
MSCI INDIA ETF
2,425,1442,425,1440$141.94M$127.66M17.33%-$14.28M
Vanguard Intl Equity Index FALLWRLD EX US507,6001,013,434+505,834$31.98M$58.18M7.90%+$26.20M
ORIC Pharmaceuticals, Inc.(ORIC)989,410989,4100$10.14M$7.98M1.08%-$2.16M
Foghorn Therapeutics Inc.(FHTX)1,573,7611,573,7610$14.65M$7.43M1.01%-$7.22M
PMV Pharmaceuticals, Inc.(PMVP)2,627,6432,627,6430$3.92M$3.97M0.54%+$52.6K
Alector Inc1,307,8581,307,8580$6.09M$2.47M0.34%-$3.62M
Tenaya Therapeutics, Inc.(TNYA)1,015,7051,015,7050$1.96M$1.45M0.20%-$507.9K
Surrozen, Inc.(SRZN)87,69687,6960$1.05M$1.26M0.17%+$207.8K
Rapt Therapeutics Inc657,899657,8990$1.32M$1.04M0.14%-$282.9K
Surrozen, Inc.W EXP 08 01 203(SRZN)170,833170,8330$1.8K$3.7K0.00%+$1.9K
23andme Holding CoCL A10,243,1220-10,243,122$3.59M$0—-$3.59M
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q4 2024 | TickerTrail